EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Exploring Disease-Specific Waitlist Outcomes in Simultaneous Liver-Kidney Transplantation

Rikako Oki, Luckshi Rajendran, Dean Yonghoon Kim, Atsushi Yoshida, Marwan Abouljoud, Shunji Nagai

Transplant International · 13.04.2026 · 39

DOI: 10.3389/ti.2026.16153 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Transplant International, online erschienen am 13.04.2026. Verfasst von Rikako Oki und 5 weiteren Autor:innen. Beteiligte Einrichtung: Transplant Institute, Henry Ford Hospital, Detroit, MI, United States. Hauptthemen laut MEDLINE: Waiting Lists, Liver Transplantation, Kidney Transplantation, Liver Diseases. Die Arbeit nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The current allocation system does not account for liver etiology in simultaneous liver-kidney transplantation (SLKT). This study aims to assess differences in waitlist outcomes among major liver disease groups (alcohol-related liver disease [ALD], metabolic dysfunction-associated steatohepatitis [MASH], hepatitis C virus infection, and biliary diseases) in SLKT using Organ Procurement and Transplantation Network (OPTN) registry. In total, 4,846 adult SLKT candidates listed between January 2018 and March 2024 were enrolled. Patients with MASH had worse waitlist 1-year mortality compared to ALD adjusted for patient characteristics at listing (HR 1.300, 95% CI 1.059–1.597, p = 0.012), whereas the 1-year SLKT probability was comparable. When patients were categorized by MELD score at listing (6–20, 21–29, and ≥30), patients with MASH had significantly higher 1-year waitlist mortality compared to those with ALD in the middle MELD score group (HR 1.365, 95% CI 1.008–1.834, p = 0.044). Prior to the allocation policy change in 2020, patients with MASH experienced higher waitlist mortality compared to ALD, however, this disparity was not observed following the policy change. Waitlist outcomes varied significantly depending on the etiology in SLKT. The revised 2020 allocation policy may be temporally associated with changes in mortality disparities across different liver etiologies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Waiting ListsLiver TransplantationKidney TransplantationLiver DiseasesHumansFemaleMaleMiddle AgedAdultRegistriesTissue and Organ ProcurementTreatment Outcome

Stichwörter der Autor:innen

allocation policy changeliver etiologymetabolic dysfunction-associated steatohepatitissimultaneous liver-kidney transplantationwaitlist outcomes

Autor:innen und Institutionen

  • Transplant Institute, Henry Ford Hospital, Detroit, MI, United States.
  • Division of Transplant and Hepatobiliary Surgery Henry Ford Hospital, Detroit, MI, United States.

Zitieren

APA

Oki, R., Rajendran, L., Kim, D. Y., Yoshida, A., Abouljoud, M., & Nagai, S. (2026). Exploring Disease-Specific Waitlist Outcomes in Simultaneous Liver-Kidney Transplantation. Transplant International, 39. https://doi.org/10.3389/ti.2026.16153

Vancouver

Oki R, Rajendran L, Kim DY, Yoshida A, Abouljoud M, Nagai S. Exploring Disease-Specific Waitlist Outcomes in Simultaneous Liver-Kidney Transplantation. Transplant International. 2026;39. doi:10.3389/ti.2026.16153

BibTeX
@article{Oki2026,
  author = {Oki, Rikako and Rajendran, Luckshi and Kim, Dean Yonghoon and Yoshida, Atsushi and Abouljoud, Marwan and Nagai, Shunji},
  title = {Exploring Disease-Specific Waitlist Outcomes in Simultaneous Liver-Kidney Transplantation},
  journal = {Transplant International},
  year = {2026},
  volume = {39},
  doi = {10.3389/ti.2026.16153}
}
Kostenlos starten →